AstraZeneca (NYSE:AZN): Q2 EPS of $1.64 beats by $0.24. Revenue of $8B (+0%) vs. $7.8B. Shares...Jul. 30, 2009 6:37 AM ETAstraZeneca PLC (AZN)AZNBy: Rachael Granby, SA News Editor AstraZeneca (NYSE:AZN): Q2 EPS of $1.64 beats by $0.24. Revenue of $8B (+0%) vs. $7.8B. Shares +3.5% premarket. (AstraZeneca's press release (.pdf)) Recommended For YouCommentsNewestPublishHave a tip? Submit confidentially to our News team. Found a factual error? Report here.More Trending NewsCatalyst Watch: McDonald's event, Lululemon earnings and GameStop volatility reduxBitcoin rally bodes well for miners’ profit prospectsPlug Power surges to top industrial gainer of week, Kanzhun sees No. 1 loser tagCharles Schwab files for mixed shelfWeight loss drugs seen providing a boost to apparel stocks - StifelSee More »About AZNSymbolLast Price% Chg1D5D1M6M1Y5Y10YMarket CapPEYield (TTM)Rev Growth (YoY)Short InterestPrev. CloseCompare to PeersRelated StocksSymbolLast Price% ChgAZN--AstraZeneca PLCRHHBY--Roche Holding AGPFE--Pfizer Inc.MRK--Merck & Co., Inc.SNY--SanofiCompareTrending AnalysisTrending News